Scleroderma, Diffuse: Clinical Trials

43 trials for Scleroderma, Diffuse, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

43 completed. 43 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable43Completed 43

Follow Scleroderma, Diffuse: new trials by email Literature Review of Scleroderma, Diffuse trials Research Report on Scleroderma, Diffuse

Trials (filtered) newest first · largest first

All 43 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Personalized Online Occupational Therapy Intervention for Adults With Scleroderma
Personalized Online Occupational Therapy Intervention, Usual Care - Scleroderma, Scleroderma (Limited and Diffuse)
Not applicableCompletedUniversidad de Zaragoza242026-05-162026-10-14
Evaluating Tools to Communicate Scleroderma Research Results to Patients - Trial #1
Plain-language summary, Dissemination Tool (Infographic) - Scleroderma, Systemic Sclerosis
Not applicableCompletedLady Davis Institute5112025-12-052026-09-10
RENEW-AI: Personalizing Scleroderma Management With an AI Health Coach
RENEW-AI - Scleroderma
Not applicableCompletedUniversity of Michigan202025-05-192025-08-20
Evaluating the Effect of Questionnaire Context on the Reporting of Somatic Items Among People With Systemic Sclerosis
Reordered PHQ-8 - Scleroderma, Systemic Sclerosis (SSc)
Not applicableCompletedLady Davis Institute8512025-01-172025-09-09
TENS in Scleroderma
Transcutaneous Electrical Nerve Stimulation - Scleroderma, Gastroparesis
Not applicableCompletedUniversity of Michigan112024-10-012026-08-13
Self-management Telehealth Program for Scleroderma
self-management program, Video guide and usual education, Telephone notification, video guide and usual education - Scleroderma
Not applicableCompletedKhon Kaen University722023-10-112025-05-30
Stress, Scleroderma and Quality of Life
Cognitive behavioral therapy - Scleroderma
Not applicableCompletedAsociación Española de Esclerodermia1502022-11-262024-02-01
Phenotyping of Chronic Pain in Diffused Systemic Scleroderma
QST, CPM and Paisudoscan - Scleroderma, Systemic, Scleroderma, Diffuse
Not applicableCompletedAssistance Publique - Hôpitaux de Paris1002022-10-192024-12-04
Quantification and Characterization of Circulating Epithelial and Endothelial Cells in Gougerot-Sjögren Syndrome, Compared to Systemic Sclerosis
Blood sampling - Primary Gougerot-Sjögren Syndrome, Systemic Sclerosis, Diffuse
Not applicableCompletedUniversity Hospital, Montpellier402022-09-272025-09-30
Scleroderma: Functional Disability Between the Dominant and Contralateral Hand.
Measurement of joint amplitudes - Scleroderma, Systemic
Not applicableCompletedUniversity Hospital, Limoges302021-12-282026-03-27
SPIN Self-Management Feasibility Trial With Progression to Full-scale Trial (SPIN-SELF)
SPIN-SELF Program - Scleroderma, Systemic Sclerosis
Not applicableCompletedLady Davis Institute1692021-09-152025-09-09
Upper Extremity Home Exercises in Patients With Scleroderma
Upper Extremity Home Exercises - Scleroderma, System; Sclerosis
Not applicableCompletedPamukkale University462021-09-102022-10-12
RENEW Scleroderma: A Peer-Mentored, Web Intervention for Resilience-based, Energy Management to Enhance Wellbeing and Fatigue
RENEW - Scleroderma
Not applicableCompletedUniversity of Michigan1742021-08-282023-11-30
Exercise With Scleroderma Functional Outcomes
Exercise Program - Scleroderma, Systemic, Scleroderma, Diffuse
Not applicableCompletedTrakya University442021-02-052024-05-22
Optical Coherence Tomography Imaging in Systemic Sclerosis
Non-invasive skin imaging assessment - Systemic Sclerosis, Early Systemic Sclerosis Without Clinical Scleroderma and Onset < 2 Years
Not applicableCompletedUniversity Hospital, Strasbourg, France602021-02-022023-08-14
Telerehabilitation on Hand-Affected Scleroderma
Hand Therapy via Telerehabilitation, Hand Therapy via home-exercises - Scleroderma, Scleroderma, Systemic
Not applicableCompletedIstanbul University422021-01-062023-04-10
Feasibility and Preliminary Effects of the Resilience-based, Energy Management to Enhance Wellbeing in Systemic Sclerosis (RENEW) Intervention
Resilience-based, Energy Management to Enhance Wellbeing (RENEW) - Scleroderma
Not applicableCompletedUniversity of Michigan212020-10-272022-09-23
The Effect of a Self-Management Program on Individuals With Scleroderma
Self Management Intervention Program - Scleroderma, Systemic Sclerosis
Not applicableCompletedEmirhan Karakuş292020-07-152023-10-23
Evaluation of the Scleroderma Patient-centered Intervention Network COVID-19 Home-isolation Activities Together Program
SPIN-CHAT Program - Scleroderma, Scleroderma, Systemic
Not applicableCompletedLady Davis Institute1722020-04-092023-02-01
Yoga Adjunct for Scleroderma
Gentle Yoga and Yogic Breathing - Scleroderma
Not applicableCompletedMedical University of South Carolina302020-01-082026-01-06

Showing 20 of 43. Sign in to see all of them.

Narrower conditions

Scleroderma, Systemic (28)  ·  Motor Activity (4)  ·  Anxiety Disorders (2)  ·  Depression (2)  ·  Gastroparesis (2)  ·  Raynaud Disease (2)  ·  Autoimmune Diseases (1)  ·  COVID-19 (1)  ·  Carpal Tunnel Syndrome (1)  ·  Chronic Pain (1)  ·  Connective Tissue Diseases (1)  ·  Coronavirus Infections (1)  ·  Disease (1)  ·  Hand Deformities (1)

Broader conditions

Skin Diseases (43)  ·  Skin and Connective Tissue Diseases (43)  ·  Connective Tissue Diseases (42)  ·  Scleroderma, Systemic (15)  ·  Behavior (7)  ·  Pathological Conditions, Signs and Symptoms (7)  ·  Pathologic Processes (4)  ·  Cardiovascular Diseases (3)  ·  Neurologic Manifestations (3)  ·  Signs and Symptoms (3)  ·  Vascular Diseases (3)  ·  Behavioral Symptoms (2)  ·  Digestive System Diseases (2)  ·  Embolism and Thrombosis (2)  ·  Fibrosis (2)

Interventions

Rehabilitation (2)  ·  Blood Specimen Collection (1)  ·  Botulinum Toxins, Type A (1)  ·  Cognitive Behavioral Therapy (1)  ·  Methylprednisolone Acetate (1)  ·  Occupational Therapy (1)  ·  Ozone (1)  ·  Physical Therapy Modalities (1)  ·  Resistance Training (1)  ·  Self-Management (1)  ·  Starch (1)  ·  Tablets (1)  ·  Tai Ji (1)  ·  Transcutaneous Electric Nerve Stimulation (1)  ·  X-Rays (1)

Sponsors

Lady Davis Institute (9)  ·  University of Michigan (7)  ·  Assistance Publique - Hôpitaux de Paris (3)  ·  Istanbul University (3)  ·  Assiut University (2)  ·  Pamukkale University (2)  ·  Asociación Española de Esclerodermia (1)  ·  Cukurova University (1)  ·  Cytori Therapeutics (1)  ·  Emirhan Karakuş (1)  ·  Emory University (1)  ·  Johns Hopkins University (1)  ·  Khon Kaen University (1)  ·  Medical University of South Carolina (1)  ·  Region Skane (1)

Countries

United States (12)  ·  Canada (9)  ·  Turkey (Türkiye) (8)  ·  France (6)  ·  Spain (2)  ·  Brazil (1)  ·  Egypt (1)  ·  Indonesia (1)  ·  Sweden (1)  ·  Thailand (1)

Top investigators

Brett D Thombs, PhD (2)  ·  Brett Thombs, PhD (2)  ·  Luc Mouthon, MD, PhD (2)  ·  Susan Murphy (2)  ·  Ayse Ayan, Dr (1)  ·  Bertolo B Manoel, MD,PhD (1)  ·  Chris Derk, MD, MSc (1)  ·  Dinesh Khanna (1)  ·  Dinesh Khanna, MD, MS (1)  ·  Emmanuel Chatelus, MD (1)  ·  Figen Yargucu Zihni, MD (1)  ·  Harry Isbagio, MD, Prof. (1)

Results publications

PMID 29381834, PMID 21312348, PMID 21951278, PMID 22470237, PMID 24812476, PMID 27384349, PMID 27696703, PMID 27941129, PMID 28081972, PMID 28552512, PMID 29198478, PMID 29325173, PMID 29667474, PMID 29685482, PMID 29696997, PMID 29741230, PMID 30079996, PMID 30318128, PMID 30809542, PMID 30835186, PMID 30886963, PMID 30886964, PMID 31130325, PMID 31216880, PMID 31219594, PMID 31482431, PMID 31719073, PMID 32062031, PMID 33448431, PMID 33899008, PMID 34030163, PMID 34069099, PMID 34337153, PMID 34838105, PMID 35219340, PMID 35234358, PMID 35358372, PMID 35382119, PMID 35945943, PMID 36307891, PMID 36510233, PMID 36708187, PMID 37597472, PMID 37846437, PMID 38526006, PMID 38618141, PMID 38622109, PMID 38910596, PMID 39327669, PMID 39552943